NEWS: FEBRUARY 2006

-02/28/2006-

Press Release: Porvair Sciences Ltd. has announced further additions to their range of low volume 384-well microplates. To read press release click here.

Press Release: Atiprimod clinical trial in advanced cancer patients uncovers clear response against carcinoid tumors. To read press release click here.

Memory Pharmaceuticals Corp. and Roche expand nicotinic alpha-7 receptor research collaboration. To read article click here.

-02/27/2006-

Eisai Inc. to open a new pharmaceutical production facility in Research Triangle Park. To read article click here.

TorreyPines Therapeutics begins second Phase I clinical trials of NGX267 for Alzheimer's Disease treatment. To read article click here.

-02/24/2006-

Chiron receives vaccine contract from the UK. To read article click here.

-02/23/2006-

Press Release: Velocity11, a pioneer in automation technology solutions for life science laboratories, has announced that it will be exhibiting its latest automated liquid handling platforms at Forumlabo in Paris, France (28-31 March 2006). To read press release click here.

Biogen Idec Inc. plans big acquisitions in the near future. To read article click here.

-02/22/2006-

Press Release: Moritex has recently finalised a deal to supply The Procter & Gamble Company, a US-based conglomerate with global presence in family health, beauty and household care markets, with a significant number of scalp moisture sensor devices. To read press release click here.

CombinatoRx Inc. discontinues CRx-140 for Psoriasis treatment. To read article click here.

Pharmacopeia and Biovitrum AB discover a new class of compounds active against a novel kinase involved in metabolic diseases. To read article click here.

-02/21/2006-

Press Release: Genevac, leader in solvent evaporation technology, has announced further additions to its range of large volume sample holders for its EZ-2 and HT series centrifugal evaporators. To read press release click here.

Press Release: Porvair Sciences Ltd. has developed a comprehensive selection of high performance Collection / Storage plates and accessories. To read press release click here.

Press Release: Peakdale extends its range of medicinal chemistry services. To read press release click here.

Novartis AG and Alnylam Pharmaceuticals Inc. form RNAi alliance to develop flu treatment using gene-level therapy. To read article click here.

CuraGen Corp.'s Phase II clinical trials of Velafermin for a cancer-related mouth sore fail. To read article click here.

-02/20/2006-

Press Release: Micronic BV, specialists in traceable sample storage solutions, have introduced Cryotube - a novel screw top tube range designed to ensure simple and high integrity storage of samples even at -180C - the vapour phase temperature of liquid nitrogen. To read press release click here.

-02/17/2006-

Roche files Herceptin for early-stage HER2-positive breast cancer in Europe. To read article click here.

-02/16/2006-

Press Release: Radleys Discovery Technologies have added several new components to their popular StarFish range to further extend its operational versatility and ease of use. To read press release click here.

Corus Pharma drops IPO. To read article click here.

Bayer Pharmaceuticals Corp. and Onyx Pharmaceuticals Inc. begin Phase III clinical trials of Nexavar® (sorafenib) in combination with carboplatin and paclitaxel for non-small cell lung cancer treatment. To read article click here.

Diversa Corp. and BASF form partnership for the development of new enzymes. To read article click here.

Speedel Holding Ltd. discloses a new series of Renin inhibitors. To read article click here.

-02/15/2006-

Amgen Inc. in $5 billion debt. To read article click here.

Aegera Therapeutics Inc. begins Phase I clinical trials of AEG35156 for acute myeloid leukemia. To read article click here.

-02/14/2006-

Press Release: Genevac, leaders in solvent removal technology, has announced several new design innovations that have enabled solvent removal times in their popular miVac centrifugal evaporator to be improved by up to 200% without loss of sample integrity. To read press release click here.

Compugen Ltd. announces the use of in-silico approach discovering novel human transcripts and proteins from "junk DNA". To read article click here.

ARIAD Pharmaceuticals Inc. begins Phase I clinical trials of oral AP23573 in combination with Doxorubicin for for a broad range of cancers and hematologic malignancies. To read article click here.

ChemDiv Inc. and SK Corporation extend research collaboration. To read article click here.

Evotec AG and Apeiron Biologics GmbH form discovery collaboration to develop small molecules for pain relief treatment. To read article click here.

-02/13/2006-

Press Release: A new technical paper is available from INTEGRA Biosciences that discusses and compares the use of different types of disposable cell culture systems for the manufacturing of biological products in mammalian cells. To read press release click here.

Genentech Inc. and Roche Holding AG stop recruiting volunteers for Phase III clinical trials of Avastin (AVANT) due to the sudden death of more patients. To read article click here.

Neose Technologies Inc. initiates Phase I clinical trials of NE-180 for anemia treatment. To read article click here.

-02/10/2006-

Johnson & Johnson cuts 300 research jobs at its research center in Raritan Borough, N.J. Johnson & Johnson's Pennsylvania site will become the new headquarters for research and early development. To read article click here and here.

FDA approves Genentech Inc. and Biogen Idec Inc.'s Rituxan for the treatment of certain types of non-Hodgkin's lymphoma. To read article click here.

-02/09/2006-

Press Release: Warwick Analytical Service, the analytical division of Exeter Analytical (UK) Ltd., has announced an expansion of its sample analysis services as a result of the recent addition of a new ICP-OES spectrometer for its laboratory. To read press release click here.

-02/08/2006-

Press Release: Porvair Sciences has announced TriSeal - its new automated heat sealer optimised for medium to high throughput plate sealing applications. To read press release click here.

Bionovo Inc. initiates Phase II clinical trials of Menopause Formula 101 (MF101) for the treatment of menopausal symptoms. To read article click here.

-02/07/2006-

Microbia Inc. and DuPont Central Research & Development from collaboration to develop biomanufacturing process. To read article click here.

Palatin Technologies Inc. and King Pharmaceuticals Inc. begin Phase IIb clinical trials of PT-141 for female sexual arousal disorder. To read article click here.

-02/06/2006-

Press Release: Argenta Discovery has implemented the StarFish™ heating and stirring workstation from Radleys to improve the use of synthetic chemistry space in several of its laboratories at its Harlow, United Kingdom, headquarters. To read press release click here.

Press Release: Available from Micronic BV, specialists in traceable sample storage solutions, is a new task dedicated instrument that accelerates the time consuming and tedious process of removing caps from sample storage tubes. To read press release click here.

The European Commission Monday approved the acquisition of Chiron Corp. by Novartis AG. To read article click here.

-02/03/2006-

GlycoGenesys files for Ch. 11 bankruptcy. To read article click here.

-02/02/2006-

Cambrex Bio Science Walkersville Inc. to acquire Cutanogen Corporation. To read article click here.

Galapagos NV and BASF extend research collaboration. To read article click here.

AtheroGenics Inc. and Astellas Pharma Inc. extend research collaboration. To read article click here.

-02/01/2006-

AngioGenex Inc. goes public. To read article click here.

Metabasis Therapeutics Inc. initiates Phse IIb clinical trials of CS-917 for type 2 diabetes treatment. To read article click here.